Tenon Medical (TNON) Director Ivan Howard Receives 10,732 Shares

What Happened Ivan Howard, a director of Tenon Medical (TNON), had 10,732 restricted stock units (RSUs) convert into 10,732 shares of common stock on July 31, 2026. The Form 4 shows an "exercise/conversion of derivative" (code M) with 10,732 shares acquired at $0.00 and a corresponding derivative disposition of 10,732 units—this reflects the settlement of RSUs into ordinary shares rather than a cash purchase or open-market sale. The filing does not report a cash value for the transaction.

Key Details

• Transaction date: July 31, 2026; Form 4 filed: August 4, 2026. (Note: Form 4s are generally due within two business days of the transaction; this filing was later than that window.)
• Reported price: $0.00 per share (conversion/settlement of RSUs).
• Shares acquired: 10,732 common shares via conversion of RSUs; corresponding derivative (10,732 RSUs) removed.
• Shares owned following the transaction: not specified in the provided filing.
• Footnotes: F1 — conversion of 10,732 RSUs granted Oct 13, 2025 into shares on Jul 31, 2026. F2 — each RSU equals one share of common stock.

Context This was a settlement/vesting event (RSUs converting to common stock), not a market purchase or sale. If the director later sells these shares, that would be reported separately. Conversions of awards like RSUs are common forms of executive/director compensation and do not by themselves indicate buy/sell intent.